USPTO serial 79137107
Serial No. 79137107
Reviewed by CopyMark Law Group
Reg. 4705701Status 706Registered
- Filing date
- Status date
- Registration date
- Mar 24, 2015
- Examiner
- GLASSER, CARYN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with Serial No. 79137107?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210-2206United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biological preparations used in industry, science and agriculture, namely, biotechnological and biological substances in the nature of cells, cell lines, nucleic acids, recombinant proteins, antigens, blood sera, antibodies and fragments thereof other than for medical or veterinary use; biotechnological products, namely, diagnostic preparations for research and diagnostic uses; biological viral preparations and biological preparations for use in cell cultures other than for medical or veterinary use; bacterial and viral substances other than for medical and veterinary uses; chemicals and biological chemical preparations for use in medical science, namely, for use in biochemical and clinical research; microorganisms, viruses, viral vectors, [ nucleic acids, ] other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Pharmaceutical products for human and veterinary uses for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; medical preparations, namely, diagnostic preparations for medical use; chemical preparations for pharmaceutical and medical purposes, namely, infectious diseases, autoimmune disorders, cancer, immunological diseases; biotechnological preparations for medical purposes, namely, medical diagnostic reagents; proteins, viral substances, immunological substances, bacterial substances, enzymatic substances, vaccines and biopharmaceutical preparations for use in human and veterinary medicine for treatment of infectious diseases, autoimmune disorders, cancer, immunological diseases; diagnostic preparations for use in human and veterinary medicine; chemical reagents for medical and veterinary purposes; cell cultures, microorganisms and viruses for medical and veterinary use; adjuvants used for medical and veterinary uses; antibiotic substances; vaccines; living cells and microorganisms as well as viral vectors, proteins, peptides and nucleic acids or complexes of these molecules for medical and veterinary purposes; antibodies and fragments thereof for use in disease testing; cells for medical, pharmaceutical and veterinary uses | ACTIVE | — |
| 042 | Scientific research and pharmaceutical development services; scientific research services in the medical, pharmaceutical and veterinary field; scientific and industrial research in particular in the field of biology, molecular biology, cell biology, biotechnology, bacteriology, immunology, [ genetics, ] medicine, pharmacology, virology, chemistry, scientific research of vaccines, [ antibiotics, ] immunological products for human and veterinary uses; research and development for novel products for the developing world; technical consultancy relating to scientific research in the scientific, medical and veterinary domain; scientific research and development and establishment of scientific and industrial research in particular for the preparation of cells, cell lines, proteins, viruses, human and animal materials; development of vaccines; [ development of medical diagnosis techniques, therapy and test methods; ] [ medical and scientific research in the field of diagnostic and prognostic analysis of human, animal, and cellular diseases; medical and scientific research in the field of diagnostic and prognostic analysis with the help of cell lines, human and animal material, microorganisms, molecules; ] chemical, medical, pharmaceutical and bacteriological scientific research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Valneva Austria GmbH
- Other trademarks owned by Valneva Austria GmbH
- Other trademarks owned by Valneva Austria GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 12, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 12, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 29, 2026 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jan 9, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 8, 2026 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| May 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| May 5, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 27, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Mar 24, 2024 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| May 18, 2023 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Oct 15, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 21, 2021 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 21, 2021 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 20, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Apr 16, 2021 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Apr 14, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Mar 30, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 29, 2021 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Jan 29, 2021 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jan 7, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 7, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 7, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jan 7, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 7, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 18, 2020 | RHRD | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED | — |
| Jul 29, 2020 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Jul 28, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 8, 2020 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Mar 24, 2020 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 6, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 10, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 21, 2015 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 6, 2015 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 6, 2015 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 24, 2015 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 3, 2015 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 24, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 18, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 18, 2015 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 6, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 6, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 17, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 17, 2014 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 17, 2014 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 4, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 3, 2014 | ALIE | ASSIGNED TO LIE | — |
| Nov 27, 2014 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 14, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 24, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 13, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 10, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 10, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2013 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 29, 2013 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 29, 2013 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2013 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 24, 2013 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 23, 2013 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 21, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 18, 2013 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |